Merck, Lilly and Amgen win again in lawsuit over drug prices in TV ads. Will it stick?

The Trump administration's quest for drug prices in TV ads just took another hit—and it might be a fatal blow. A U.S. appeals court agreed with a lower court ruling that found the U.S. Department of Health and Human Services (HHS) didn't have the authority to require them.